On September 5, 2026, leading UK clinical patient groups updated guidelines for sourcing unlicensed oncology medications under Medicines and Healthcare products Regulatory Agency (MHRA) rules. Sourcing specialty cancer therapies from international suppliers requires careful compliance with UK import regulations. Ensuring that documentation is complete and that the cold-chain is verified prevents delays at the border and protects patient safety.

At Onco Medicine, we facilitate secure delivery under MHRA guidelines, ensuring that patients and clinics across the UK can access essential oncology treatments safely.

MHRA Personal Importation Scheme Rules

The UK allows individuals to import medications for personal use, provided the following requirements are met:

• Oncologist Prescription: A valid prescription from a registered UK oncologist or clinician is required.
• 3-Month Limitation: Shipments are limited to a maximum 3-month (90-day) supply per import order.
• Unlicensed Medicine Access: Sourcing is restricted to medicines that are either not available or not yet licensed in the UK but are necessary for patient survival.

Customs Documentation Pack

For border clearance, each package must contain a complete set of documentation:

• Signed Prescription: A copy of the patient's UK prescription.
• Certificate of Analysis (COA): Batch verification from the manufacturer.
• Commercial Invoice: Detailing pricing, manufacturer details, and delivery address.

Contact our UK support desk at support@onco-medicine.com or message our pharmacist on WhatsApp +91 94275 19809.